AstraZeneca Covid-19 vaccine can be 90 percent effective
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil positive interim data in a…
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil positive interim data in a…
Swiss doctors have urged those vulnerable to COVID-19 complications to record their wishes for end-of-life care in advance to help ease pressure on intensive care units, drawing criticism from an…
Gilead’s remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for…
People who’ve had COVID-19 are highly unlikely to contract it again for at least six months after the first infection, according to a British study of healthcare workers on the…
CORONAstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.…
Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. The…
WHO Director-General, Dr Tedros Adhanom Ghebreyesus The World Health Organization (WHO) on Tuesday launched the global strategy to accelerate the elimination of cervical cancer globally. Outlining three key steps to…
WHO Director-General Tedros Adhanom Ghebreyesus The World Health Organization (WHO) said on Monday there had been 65 coronavirus infections among staff at its Geneva headquarters since the start of the…
Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a…
This week has seen a flurry of good news from Covid-19 vaccine developers, with Pfizer Inc. and BioNTech SE trumpeting early data indicating their mRNA candidate is more than 90%…